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The  distinctive  and  unique  features  of  the  avian  and  mammalian  zoonotic  pathogen  Chlamydia  (C.) psittaci
include  the  fulminant  course  of  clinical  disease,  the  remarkably  wide  host  range and  the  high  proportion  of
latent  infections  that are  not  leading  to  overt  disease.  Current  knowledge  on  associated  diseases  is rather
poor,  even  in  comparison  to  other  chlamydial  agents.  In the  present  paper,  we  explain  and  summarize
the  major  ﬁndings  of  a  national  research  network  that focused  on the  elucidation  of  host–pathogen
interactions  in vitro  and  in animal  models  of  C.  psittaci  infection,  with  the  objective  of  improving  our
understanding  of  genomics,  pathology,  pathophysiology,  molecular  pathogenesis  and  immunology,  and
conceiving  new  approaches  to therapy.  We  discuss  new  ﬁndings  on comparative  genome  analysis,  the
complexity  of pathophysiological  interactions  and  systemic  consequences,  local  immune  response,  the
role  of  the  complement  system  and  antigen  presentation  pathways  in  the  general  context  of state-of-the-
art knowledge  on  chlamydial  infections  in humans  and  animals  and  single  out relevant  research  topics
to  ﬁll remaining  knowledge  gaps  on  this  important  yet  somewhat  neglected  pathogen.
©  2014  The  Authors.  Published  by  Elsevier  GmbH.  This  is an  open  access  article  under  the CCntroduction
The ﬁrst deﬁnition of Chlamydia (C.)  psittaci was formulated in
968 to distinguish it from C. trachomatis, the only other known
hlamydial species at that time, and was based on the inability
o accumulate glycogen in its inclusions and resistance to sulfa-
iazine (Page, 1968). More recently, the species was  redeﬁned to
omprise mainly avian strains, but at the same time assigned to the
eparate genus Chlamydophila (Everett et al., 1999). The latter has
een abolished in the meantime (Kuo et al., 2011; Stephens et al.,
009), so that C. psittaci is now one of nine accepted members of the
ecombined genus Chlamydia.  Two more avian chlamydiae (Sachse
t al., 2014) and one Candidatus taxon (Vorimore et al., 2013) were
iscovered recently and are about to be added to the same genus.
∗ Corresponding authors.
E-mail addresses: michael.knittler@ﬂi.bund.de (M.R. Knittler),
onrad.sachse@ﬂi.bund.de (K. Sachse).
ttp://dx.doi.org/10.1016/j.ijmm.2014.06.010
438-4221/© 2014 The Authors. Published by Elsevier GmbH. This is an open 
icenses/by-nc-nd/3.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
The groundwork for modern chlamydia research was  laid in
the 1960s and 1970s by the pioneering work of J.W. Moulder,
A. Matsumoto, G.P. Manire, T.P. Hatch, P.B. Wyrick and several
other scientists, who  focused on C. psittaci in their studies. By
analyzing the structure and chemical composition of isolated C.
psittaci “particles”, Moulder (1962) conducted one of the ﬁrst
molecular characterizations of chlamydiae. Based on experiments
with C. psittaci-infected cells, Matsumoto and Manire (1970) were
the ﬁrst to provide high-resolution images of chlamydial bod-
ies and to describe effects of antibiotics on their morphology.
The groundbreaking studies of Hatch (1975) demonstrated that
chlamydiae owe their obligate intracellular mode of reproduc-
tion to the requirement for energy intermediates produced by the
host cell. Not least, Wyrick and colleagues (1978) were the ﬁrst to
describe structural properties of chlamydial compartments (Narita
et al., 1976) and the ability of C. psittaci to infect immune cells
(Wyrick and Brownridge, 1978).
C. psittaci is the causative agent of psittacosis (sometimes also
called ornithosis or parrot fever), the most important animal
access article under the CC BY-NC-ND license (http://creativecommons.org/
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hlamydiosis of zoonotic character. This systemic disease can take
cute, protracted, chronic or subclinical courses and mainly affects
sittacine birds and domestic poultry (Andersen and Vanrompay,
000; Kaleta and Taday, 2003). Typical symptoms include lethargy,
yperthermia, abnormal excretions, respiratory distress, nasal and
cular discharges, weight loss and reduced egg production. C.
sittaci infections and ensuing disease outbreaks are economically
elevant to the poultry industry and signiﬁcantly compromise ani-
al  welfare (Yin et al., 2013). Recent data also indicate that, in
oncert with C. trachomatis, C. psittaci may  play a role in human
rachoma (Dean et al., 2013).
The zoonotic dimension of avian chlamydiosis is another cause
or concern, as cases of bird-to-man transmission are regularly
eported in the literature (Gaede et al., 2008; Harkinezhad et al.,
009; Heddema et al., 2006; Laroucau et al., 2009). The fact that
he overall number of reported cases remained generally low in
he past decades is, to some extent, due to the absence of this
athogen in most routine diagnostic schemes. The symptoms in
ffected individuals are mainly non-speciﬁc and inﬂuenza-like, but
evere pneumonia, endocarditis and encephalitis are not uncom-
on  (Salisch et al., 1996). While it is generally perceived that the
ourse and severity of disease depend on virulence properties of
he C. psittaci strain involved, the immune response of the host, as
ell as transmission route and infectious dose, very little is known
n concrete terms about any parameter of host–pathogen interac-
ions. Furthermore, latent infection seems to be more widespread
han clinical cases, both among birds and humans. It was  shown in
everal studies in cattle that, in the absence of clinical signs, per-
ormance and health parameters of chlamydia carriers were clearly
nferior to those of chlamydia-free animals (reviewed in Reinhold
t al., 2011b). In this context, frequently observed recurrent infec-
ions by chlamydiae might pave the way for chronic disease.
The remarkable variety of clinical manifestations displayed by
. psittaci and chlamydial infections in general should, at least in
art, be explicable through the distinctive features of the causative
gent. C. psittaci is an obligately intracellular bacterium with a
nique biphasic developmental cycle. It exists in basically two
orphological stages, the infectious, but metabolically inactive ele-
entary body (EB) and the non-infectious, but metabolically active
eticulate body (RB). In the course of a replication cycle, EBs evolve
nto RBs in a vacuole-like inclusion of the host cell, where the
atter undergo binary ﬁssion before transforming back into EBs
o start a fresh cycle. The natural development can be halted at
he intracellular stage through the action of adverse factors, such
s interferon (IFN)-  exposure, iron or amino acid depletion, and
ntibiotic treatment (Beatty et al., 1994; Wyrick, 2010). This per-
istent state is characterized by aberrant (enlarged) morphology of
Bs, loss of cultivability and rescue of infectivity upon removal of
nducers. In the case of C. psittaci,  induction of persistence in vitro
as accompanied by consistent downregulation of membrane pro-
eins, chlamydial sigma factors, cell division protein and RB–EB
ifferentiation proteins from 24 h post-infection onwards (Goellner
t al., 2006). While it is not yet clear whether the host immune
esponse can actually trigger transition of chlamydial bodies into
he persistent state, although some evidence seems to suggest
t (Borel et al., 2008; Pospischil et al., 2009), these observations
rovide an explanation for the failure of antibiotic treatment to
liminate chlamydial agents from an infected organism (Reinhold
t al., 2011a).
Host preference of C. psittaci is an interesting yet largely unex-
lored topic. As the agent is generally referred to as an avian
athogen, there is still a widely held notion that it occurs only in
irds. However, a number of surveys showed that C. psittaci can
e found frequently in non-avian domestic animals, such as cat-
le (Kemmerling et al., 2009), sheep (Lenzko et al., 2011), swine
Kauffold et al., 2006; Vanrompay et al., 2004), horses (Szeredi et al.,dical Microbiology 304 (2014) 877–893
2005; Theegarten et al., 2008), goats and cats (Pantchev et al., 2010),
as well as in wildlife (Hotzel et al., 2004) and laboratory rodents
(Henning et al., 2008). Although the role of the agent in these hosts
remains to be clariﬁed it seems certain that overt clinical manifes-
tations are rare exceptions. In addition, the virulence to humans
of non-avian C. psittaci strains appears to be negligible compared
to avian isolates, since the reported cases of human psittacosis are
usually traced back to contact with an avian source. Nevertheless,
no genetic markers to distinguish between avian and non-avian
strains have been found in comparative genomic studies (Voigt
et al., 2012), nor have any virulence criteria been identiﬁed (Read
et al., 2013). One can hypothesize from these ﬁndings that birds are
the original and typical host for C. psittaci, while mammals merely
act as alternate hosts and any passages of avian strains through
non-avian hosts are accompanied by loss of virulence. Apart from
these considerations, the factors determining host preference and
adaptation of chlamydiae are largely unclear.
Comparative genomics: C. psittaci – a typical member of the
family Chlamydiaceae with unique features
Second-generation sequencing efforts have led to the comple-
tion of more than 100 chlamydial genome sequences encompassing
all recognized species, except C. suis. For C. psittaci,  whole-genome
sequences of 28 strains have become available so far (http://ftp.
ncbi.nlm.nih.gov/genomes/ASSEMBLY BACTERIA/Chlamydia
psittaci/), covering virtually all serotypes and avian and mam-
malian hosts (Grinblat-Huse et al., 2011; Schoﬂ et al., 2011;
Seth-Smith et al., 2011, 2013; Van Lent et al., 2012; Voigt et al.,
2011). This wealth of data allows unprecedented insights in
the genomic organization, evolutionary dynamics, and genetic
diversity of the species.
Comparative analysis of chlamydial genomes showed a high
level of sequence and gene order conservation (shared synteny)
across members of the family and, as in other obligate intracellular
bacteria, a considerably reduced genome, implying dependency on
the host organism for many metabolic capabilities. All sequenced
C. psittaci strains possess a single chromosome of approximately
1.1 Mb,  and a conserved plasmid of ∼8 kb containing 7–8 protein-
coding sequences (CDS) was reported for 12 strains. A total of
911 core CDS are shared among all currently sequenced C. psittaci
strains, which is equivalent to about 90% of the genes present
in each of these genomes (Read et al., 2013). Among the species
of C. psittaci, C. abortus, C. pneumoniae, and C. trachomatis, 736
genes are still shared (with a total CDS count ranging from 874
to 1097), which illustrates the degree of conservation across chla-
mydial genomes (Voigt et al., 2012). In contrast, one of the closest
relative of Chlamydiaceae for which a genomic sequence is avail-
able, Simkania negevensis,  features a genome of more than twice
this size with a chromosome of 2.5 Mb  and ∼2500 predicted CDSs
(Collingro et al., 2011).
Conserved synteny is extremely high among most chlamyd-
ial genomes. Major genomic rearrangements are present only
between the closely related C. trachomatis and C. muridarum versus
the remainder of the Chlamydiaceae (Fig. 1). Major deviations from
synteny and/or sequence conservation, however, can be observed
in genes encoding inclusion membrane proteins, in the hyper-
variable region near the predicted replication termination region
known as the plasticity zone (PZ), as well as among the fam-
ily of polymorphic membrane protein (pmp) genes (Fig. 1). These
regions are assumed to harbor key genomic correlates to species-
speciﬁc adaptation (see also Section “Host adaptation of C. psittaci:
Escape from the avian innate immune response”) to environmental
niches, tissue tropism and differences in virulence and pathogeni-
city (Thomson et al., 2005).
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Fig. 1. Comparative genomics. Maximum-likelihood tree based on a random sample of 100 conserved orthologous genes and global comparison of synteny among the eleven
fully  sequenced species of the family Chlamydiaceae (C. ibidis is a taxon with Candidatus status). Gray tick marks above and below the sequence lines represent predicted
CDSs  on the plus and minus strands of the genomes, respectively. Color-marked are (blue) members of the polymorphic membrane protein (Pmp) family and (green) genes
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The size and organization of the PZ differs substantially among
hlamydiaceae, ranging from 45 genes in C. trachomatis to six genes
n koala strain LPCoLN of C. pneumonia (Voigt et al., 2012). The
Z of C. psittaci is remarkable for its inclusion of a large intact
oxin/adhesin gene similar to the EHEC adherence factor, as well
s a guaAB-add cluster, which plays a role in salvaging biosynthesis
f purine nucleotides necessary for bacterial growth. These genes
re shared with C. caviae and C. felis, but are absent (or predicted
o have loss-of-function frameshifts) in other chlamydial species,
ncluding the closely related C. abortus (Voigt et al., 2012). Interest-
ngly, a recent comparative analysis of 20 C. psittaci strains revealed
hat only a subset of C. psittaci strains, the monophyletic“6BC clade”,
nd its closest relatives may  have acquired these genes through a
ingle event of horizontal gene transfer, or they may  have been
ost from or degraded in more basal clades of C. psittaci on three
ndependent occasions (Read et al., 2013). The 6BC clade com-
rises 10 strains including type strain 6BC/30 isolated from a parrot
Grinblat-Huse et al., 2011), and contains strains of both avian and
ammalian origin corresponding to serotypes A and B (Read et al.,
013). In contrast, two further clades including serotypes C and
 comprise only avian hosts. The 6BC clade shows extremely little
nternal variability (483 polymorphic nucleotide positions) coupled
ith a distinct lack of host speciﬁcity (Read et al., 2013). Interest-
ngly, signiﬁcant sequence differences between 6BC and non-6BC
lades were observed in the large toxin locus. It is tempting to spec-
late that these remarkable differences among C. psittaci strains
ay  have conferred adaptive advantages that facilitated host range
xpansion in the 6BC lineage.
In several chlamydial species, including C. psittaci, pmp genes
ave undergone a signiﬁcant proliferation resulting in unusually
igh levels of mutational change within and across species. The
mps are a large protein family, probably unique to the chlamydiae,
ith low overall amino acid similarity, but sharing multiple, often
lternating motifs GGA (ILV) and FxxN. They are considered to be
mportant in EB adhesion to host cells, molecular transport, and
ell wall-associated functions (Longbottom et al., 1998), and have
een identiﬁed as a critical factor in chlamydial pathogenesis (Tan
t al., 2006). Pmps cluster phylogenetically into six subfamilies andct orthologous matches based on best reciprocal BLAST hits; blue lines represent
are present in varying numbers ranging from a total of nine genes
in C. trachomatis and C. muridarum to 21 in C. pneumoniae and C.
psittaci (Voigt et al., 2012). Subfamily G/I is the largest and most
rapidly evolving representative (Voigt et al., 2012). The tendency
to proliferation of G/I family Pmps is especially pronounced in C.
psittaci and its closest relatives, as well as in C. pneumoniae. While
there are only two G/I pmp genes present in C. trachomatis and C.
muridarum, there are 14 G/I family pmp genes present in the C.
psittaci genome, several of which are unique to this species (Voigt
et al., 2012). It has been suggested that the diversity in the pmp
family of genes may  have evolved in response to demands of the
host environment, e.g. to escape systemic host response or adapt to
multiple host environments (Tan et al., 2006). Thus, the extremely
high variability of pmp genes in C. psittaci may also be related to its
broad host spectrum.
While homologous recombination is a fundamental mechanism
for genetic diversiﬁcation in free-living bacteria, it is often thought
to be limited in obligate intracellular bacteria, whose lifestyle
should rarely allow encounters with sources of foreign DNA. With
many genomes from the same species becoming available, it has
become possible to apply traditional population genetics meth-
ods to whole genomes in order to test predictions as above with
high precision. Thus, analysis of a large number of C. trachomatis
genomes recently provided compelling evidence for relatively
frequent homologous recombination in this species, despite the
ecological barriers to contact posed by an intracellular lifestyle
(Joseph et al., 2012). Similar evolutionary dynamics also play a
surprisingly strong role in C. psittaci, where recombination events
are spread evenly across the genome and were estimated to occur
at roughly 1/20th the rate of mutation events. However, although
recombination was  less frequent than mutation, it accounted for
three times more substitutions in a genome, because each recom-
bination event affected several nucleotides at a time (Read et al.,
2013). Strikingly, BLAST analysis of predicted recombinant seg-
ments indicated that roughly 50% of putative DNA imports derive
from C. abortus or as-yet unknown/unsampled C. psittaci strains.
This suggests that there is still substantial diversity in C. psittaci to
be uncovered at the genome level.
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linical pathology: The course of C. psittaci respiratory
nfection in a natural non-avian host
Animal models closely mimicking the relevant characteristics
f human disease are still a key element for evaluating patho-
hysiological consequences and for understanding the underlying
echanisms of disease pathogenesis. Moreover, a valid animal
odel is a prerequisite for development and efﬁcacy testing of
herapeutics and vaccines.
With respect to research on respiratory C. psittaci infections, the
ovine species offers a number of advantages stated in detail else-
here (Reinhold et al., 2012). Morphological peculiarities of the
ovine lung, including segmental anatomy and the lack of collat-
ral airways, mirror pathophysiological mechanisms of pulmonary
ysfunctions more clearly. The availability of a range of highly sen-
itive, non-invasive pulmonary function tests known from human
edicine and previously validated for calves enables detailed eval-
ation of nature and scope of pulmonary disorders (Ostermann
t al., 2014). Additionally, the body size of calves facilitates repeated
ampling of biological specimens (e.g. blood and swabs), and thus
ollow-up monitoring of clinical and immunological parameters
see also Section “Local immune response: Development and res-
lution of pulmonary lesions after C. psittaci infection of calf and
ouse”). A calf model using a bovine C. psittaci strain potentially
llows detailed monitoring of transmission routes, molecular and
hysiological processes in the course of infection, as well as evalu-
tion of a strain’s virulence. The data obtained should be of interest
or researchers in both veterinary and human medicine. In a recent
eries of infection trials, we were able to demonstrate and verify
he essential characteristics of a C. psittaci infection in its various
anifestations (Ostermann et al., 2013a,b, 2014; Reinhold et al.,
012).
First of all, the severity of disease during the acute phase
f infection (Fig. 2A) proved clearly dose dependent. Respira-
ory and clinical signs, which peaked 2–3 days post-inoculation
dpi), were mild after inoculation of 106 inclusion-forming units
ifu) of C. psittaci strain DC15 per calf, moderate with doses of
07–108 ifu and severe for 109 ifu. This dose–response relation
as highly reproducible in extent and quality of lung lesions,
nd also reﬂected in respiratory functions affecting pulmonary gas
xchange (Ostermann et al., 2013b; Reinhold et al., 2012). Baseline
ffects due to chlamydial LPS or cell culture medium were ruled
ut by using controls that received UV-inactivated chlamydiae or
edium, respectively.
Secondly, we were able to reproduce the whole variety of
haracteristic features that are observed in animals and humans
ffected by natural chlamydial infections. In the case of calves
ntra-bronchially inoculated with 108 ifu/calf, a typical course
ncluded initial acute clinical illness (2–3 dpi), which subsided
onsiderably, but not completely, within 10 dpi (Ostermann
t al., 2013a). Subsequently, a protracted clinically silent course
as indicated by intermittent mild symptoms, fecal pathogen
xcretion, transient chlamydemia, and slightly elevated levels
f monocytes and lipopolysaccharide-binding protein (LBP) in
lood. Interestingly, these phenomena were also observed as
 consequence of naturally acquired, initially mild infection, as
nduced in a group of naïve calves (sentinels) that socialized with
he acutely diseased animals. Again, this underlines the validity
f the present bovine infection model and its potential to emulate
he natural circumstances. The fact that neither group of calves
ompletely eliminated the chlamydiae within ﬁve weeks after
xposure (Ostermann et al., 2013a) is also in line with observations
n animal herds, where (permanent or intermittent) carriers of
hlamydiae represent a permanent reservoir for recurrent out-
reaks of disease (Reinhold et al., 2011b). Under ﬁeld conditions,
ven asymptomatic chlamydial infections in cattle herds aredical Microbiology 304 (2014) 877–893
known to be associated with numerous negative effects on health
and performance including signiﬁcantly reduced growth rate in
calves (Jaeger et al., 2007; Poudel et al., 2012; Reinhold et al., 2008).
Thirdly, the humoral immune response was generally weak
(see also Section “Local immune response: Development and res-
olution of pulmonary lesions after C. psittaci infection of calf and
mouse”). Only two-thirds of calves experimentally challenged with
108 ifu developed speciﬁc antibodies against C. psittaci as detected
by immunoblotting. The onset of the antibody response occurred
between 7 and 14 dpi. In sentinels, no humoral immune response
was observed (Ostermann et al., 2013a; Reinhold et al., 2012).
Although innate and acquired humoral immunity are also criti-
cally involved in the clearance of chlamydiae, this supports the
notion that the cellular immune response plays a central role in con-
trolling anti-bacterial immunity in infected hosts (see also Section
“The cellular immune response: New insights into MHC  I-mediated
presentation of chlamydial antigens”) and also imposes basic con-
straints on disease control approaches based solely on classical
immunoprophylaxis.
Fourthly, the pathological manifestations of acute respiratory C.
psittaci infection included inﬂammatory cells (mainly neutrophil
granulocytes) recruited onto the site of infection (Figs. 2B and 3B;
see also Sections “Local immune response: Development and res-
olution of pulmonary lesions after C. psittaci infection of calf and
mouse” and “The innate immune response and its interaction
with the adaptive response: Chlamydial infection and the com-
plement system”). Pulmonary inﬂammation resulted in damage
of the alveolar-capillary barrier, as indicated by altered cytol-
ogy, elevated concentrations of eicosanoids and total protein in
broncho-alveolar lavage ﬂuid (Reinhold et al., 2012). Inﬂamma-
tion and the accumulation of detritus and protein-rich ﬂuid caused
(i) ventilatory disorders due to both airway obstructions and pul-
monary restrictions and (ii) inhibited pulmonary gas exchange.
Among the resulting functional consequences were reduced alveo-
lar ventilation (hypoventilation) and reduced oxygen supply to the
blood (hypoxemia). Attempts of compensation included the ele-
vation of both respiratory rate and minute ventilation, clinically
visible as dyspnea (Ostermann et al., 2013b, 2014).
Pulmonary dysfunctions were accompanied by metabolic dis-
orders in the acid–base equilibrium revealing additional systemic
consequences of an acute C. psittaci infection on blood pH and blood
homeostasis in the host (Ostermann et al., 2014).
Taken together, the bovine model of respiratory C. psittaci
infection revealed unprecedented insights into the very complex
interactions between pathological changes, pathophysiological
consequences and clinical signs induced by this pathogen in the
mammalian host (Fig. 2B). With respect to comparative and trans-
lational medicine, this model builds a useful bridge between basic
molecular research and clinical work in patients, both humans and
animals. The elucidated host–pathogen interactions provide a suit-
able basis for further research focusing on new strategies to control
this infection through treatment or vaccination.
Local immune response: Development and resolution of
pulmonary lesions after C. psittaci infection of calf and
mouse
In recent studies, pulmonary lesions were investigated in mod-
els of experimental aerogenous infection with C. psittaci in calves
(see Section “Clinical pathology: The course of C. psittaci respira-
tory infection in a natural non-avian host”) and mice (see Sections
“The innate immune response and its interaction with the adaptive
response: Chlamydial infection and the complement system” and
“The cellular immune response: New insights into MHC  I-mediated
presentation of chlamydial antigens”) to analyze species-speciﬁc
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Fig. 2. Respiratory Chlamydia psittaci infection: complexity of pathogenetic mechanisms, pathophysiological interactions and systemic consequences in the mammalian host
(bovine  model). (A) Pulmonary lesions in the bovine lung. The section through a cranial lobe reveals several lobules with ﬁbrinopurulent bronchopneumonia (asterisks) in
close  association with bronchi (arrows) in a calf 4 days after experimental inoculation with C. psittaci. (B) Inoculation of C. psittaci resulted in infection and replication of
the  pathogen in pulmonary epithelial cells and initiated an acute-phase reaction. Pro-inﬂammatory chemokines activated the inﬂammation cascade with recruitment and
accumulation of phagocytic and reactive immune cells from the blood into the lung. Tissue damage and leakages of the alveolo-capillary membrane enabled a spillover of
the  pathogen into the bloodstream (chlamydemia). Within the lung, ﬂuid, cells and debris in the alveoli and the interstitial tissue provided a barrier for oxygen transfer
leading  to oxygen deﬁciency in arterial blood (hypoxemia). Additional interacting factors induced by inﬂammatory mediators diminished multiple pulmonary functions.
Analysis  of respiratory mechanics revealed restriction of pulmonary tissue (i.e. limitations in lung compliance) and airway obstructions, both contributing to a reduction
in  alveolar ventilation (alveolar hypoventilation). Regarding the breathing pattern, expiration was more impaired than inspiration, which resulted in ‘apped air’, i.e. larger
end-expiratory gas volume in the alveolar spaces due to incomplete deﬂation of the lung (i.e. increased functional residual capacity; FRC). The latter worsened the already
existing alveolar hypoventilation and the already reduced oxygen delivery to the blood. In hypoventilated areas of the lung, the corresponding pulmonary arteries constricted
(hypoxic pulmonary vasoconstriction; HPV), and those stiffer blood vessels with increased vascular resistance deteriorated the loss of compliant pulmonary properties. In the
less  compliant lung, the volume inhalable and exhalable per breath (tidal volume) was reduced. Due to the lack of oxygen in the blood, however, respiration was stimulated
resulting in a compensatory increase of the respiratory rate and the volume of minute ventilation. Clinically, short, rapid breathing cycles appeared that were characterized
by  an increased percentage of dead space ventilation and a reduced percentage of alveolar ventilation. Tissue damage and pulmonary dysfunctions had a strong impact on
acid–base equilibrium. While alveolar hypoventilation may  result in accumulation of CO2 in the body (hypercapnia) and a consecutive respiratory acidosis (blood pH ↓), the
attempt  to compensate hypoxemia by a dramatically intensiﬁed respired volume per time (hyperventilation) was associated with a loss of CO2 (hypocapnia) driving blood
pH  in the direction of respiratory alkalosis (pH ↑). In addition, the demand of oxygen in peripheral tissues in relation to a reduced oxygen supply by the blood stimulated
anaerobe metabolism (increased production of l-lactate and protons), which inﬂuenced blood pH in the direction of metabolic acidosis (pH ↓). Additional complex metabolic
inﬂuences on blood pH are described in Ostermann et al. (2014). In general, numerous acidic effects were counterbalanced by a variety of alkalotic effects inﬂuencing the
a transl
o teract
r
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pcid–base equilibrium in the host organism in multiple ways. In comparative and 
ur  understanding of pathogenetic mechanisms and complex pathophysiological ineaction patterns to the pathogen (Fiegl et al., 2013; Lambertz,
011; Möhle, 2011; Reinhold et al., 2012).
In calves, intra-tracheal application of viable C. psittaci induced
neumonia in all animals inoculated (Fig. 2), but in none of theational medicine, this integrated large animal model has fundamentally improved
ions during respiratory C. psittaci infection.controls (Reinhold et al., 2012). In addition to the dose-dependent
clinical score (see Section “Clinical pathology: The course of C.
psittaci respiratory infection in a natural non-avian host”), the type
of lesions changed with increasing dose of inoculum from purulent
882 M.R. Knittler et al. / International Journal of Medical Microbiology 304 (2014) 877–893
Fig. 3. Pulmonary lesions (A–D) and model of local immune response to Chlamydiae (E). Pulmonary lesions 4 days after experimental inoculation of a calf (A and B) and a
mouse  (C and D) with C. psittaci. Lesions in the calf (A) are characterized by ﬁbrinopurulent exudate and foci of necrosis (N), whereas neutrophilic inﬁltrates predominate
in  the mouse (C). Numerous chlamydial inclusions (brown) are present in intra-lesional neutrophils and macrophages of calf (B) and mouse (D). A, C bars = 100 m.  B, D
bars  = 200 m.  In the model of local immune response to chlamydiae (E), infected alveolar epithelial cells secrete interleukin-8 (IL-8), which is a potent pro-inﬂammatory
cytokine playing a key role in recruitment and activation of neutrophils. Neutrophils produce enzymes and reactive oxygen species to kill bacteria and provide the ﬁrst
line  of defense against chlamydiae together with macrophages and dendritic cells (DCs). Binding of conserved pathogen-derived molecules by speciﬁc receptors on the cell
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o ﬁbrinous to necrotizing. Thus, the type of acute lesions differed
istinctly from the interstitial and atypical pneumonia generally
eported in calves and humans (Beeckman and Vanrompay, 2009;
ee et al., 2004).
The time course of infection was followed in inoculated calves
rom 2 days to 1 month after inoculation (Lambertz, 2011; Möhle,
011). The pneumonic exudate predominantly consisted of neu-
rophil granulocytes (see also Sections “Clinical pathology: The
ourse of C. psittaci respiratory infection in a natural non-avian
ost” and “The innate immune response and its interaction with
he adaptive response: Chlamydial infection and the complement
ystem”) at 2 and 3 dpi. Lesions were most severe at days 3 and
 pi with ﬁbrinous exudate, areas of necrosis and increasing num-
ers of alveolar macrophages (Fig. 3A). Chlamydial inclusions were
etected initially in alveolar epithelial cells and then increasingly
n neutrophil granulocytes and alveolar macrophages, especially
n areas of necrosis (Fig. 3B). Ultrastructural investigation revealed
nfection of alveolar epithelial cells, neutrophil granulocytes and
lveolar macrophages with C. psittaci, but multiplication was seen
n alveolar epithelial cells only. At day 7 pi, ﬁrst signs of regen-
ration were seen: necrotic pulmonary tissue was demarcated
y proliferating alveolar epithelial cells and dense inﬁltrates of
acrophages. The zones of regeneration became conﬂuent at day
0 pi and were inﬁltrated by dendritic cells (DCs) (see also Section
The cellular immune response: New insights into MHC  I-mediated
resentation of chlamydial antigens”), macrophages, T and B lym-
hocytes and plasma cells. At day 14 pi, the numerous lymphocytes,
acrophages, DCs and ectopic lymphoid follicles in the lesions
ndicated a strong local immune response that caused a marked
eduction of the number of chlamydiae. The pulmonary tissue had
egenerated one month pi except for a few small foci of ﬁbrous
car tissue. Number and distribution of unorganized immune cells
ere comparable to control calves, but bronchus-associated lym-
hoid tissue was more pronounced. The intrapulmonary infection
f calves with C. psittaci allows a detailed study of the steps hypoth-
sized to be involved in the development and organization of lung
amage in animals and humans (Beers and Morrisey, 2011).
For the zoonotic agent C. psittaci,  knowledge about shedding
nd potential routes of transmission is important. The detection of
. psittaci in nasal mucosa and trachea from 2 to 4 days pi was
nterpreted as excretion of the pathogen with infected exudate
rom the lung, since chlamydial inclusions were detected in lumi-
al exudate in the trachea by immunohistochemistry. The excretion
as limited to the short time period of severe lesions and to low
umbers of chlamydial inclusions in the exudate (Lambertz, 2011).
issemination of C. psittaci from the infected lung to sites that are
onsidered to be preferential targets for chronic chlamydial dis-
ases in humans, e.g. aorta and synovial membranes, was detected
y PCR. The lack of tissue reaction in these target tissues argues
gainst an active infection and conﬁrms ﬁndings from infection
xperiments in rabbits with C. pneumonia (Gieffers et al., 2004).
In another experimental setting, mice were intranasally inocu-
ated with the same strain of C. psittaci that was used in calves (see
ections “The innate immune response and its interaction with the
daptive response: Chlamydial infection and the complement sys-
em” and “The cellular immune response: New insights into MHC
-mediated presentation of chlamydial antigens”). The initial phase
f infection was similar in both species. At day 4 pi, differences
n reaction of mice versus calves became apparent, i.e. extensive
urulent inﬂammation with increasing numbers of macrophages
urface of macrophages and DCs activates the production of pro-inﬂammatory cytokines
hlamydia-activated DCs present bacteria-derived antigens to T cells and promote the di
D4+  T helper 1 (Th1) cells secrete IFN-, which activates the anti-microbial activity of m
h2  cells provide help for B-cell production of antibodies.dical Microbiology 304 (2014) 877–893 883
was found in mice (Fig. 3C), while calves developed severe ﬁbri-
nous exudation with tissue destruction (Fig. 3A). Large numbers
of chlamydiae were associated with neutrophil granulocytes and
macrophages in the lesions of both hosts (Fig. 3B and D). The dif-
ferent types of inﬂammatory lesions resulted in distinct healing
processes, i.e. mice developed lymphohistiocytic bronchointersti-
tial pneumonia, whereas regeneration with alveolar epithelial type
2 cell hyperplasia occurred in calves. Both mounted a massive local
immune response that eliminated the chlamydiae (see also Sec-
tions “The innate immune response and its interaction with the
adaptive response: Chlamydial infection and the complement sys-
tem” and “The cellular immune response: New insights into MHC
I-mediated presentation of chlamydial antigens”).
Based on the morphological ﬁndings, the following hypothesis
for the pathogenesis of pulmonary C. psittaci infection can be sug-
gested (Fig. 3E). There is an initial infection of alveolar epithelial
cells with C. psittaci. The multiplication of C. psittaci is followed
by a rapid inﬂux of neutrophil granulocytes most likely medi-
ated by cytokines released from infected cells (see Sections “The
innate immune response and its interaction with the adaptive
response: Chlamydial infection and the complement system” and
“The cellular immune response: New insights into MHC  I-mediated
presentation of chlamydial antigens”). These initial steps of the
inﬂammatory reaction are consistent with the “cellular paradigm”
in chlamydial infections (Stephens, 2003). Degranulation and decay
of neutrophil granulocytes cause extensive species-speciﬁc dam-
age of the pulmonary tissue. Progressive elimination of C. psittaci by
adaptive immune response including DCs (see Section “The cellular
immune response: New insights into MHC  I-mediated presentation
of chlamydial antigens”), T and B cells and regeneration of the pul-
monary tissue follow. These ﬁndings go beyond the results from the
large number of studies where only lesions at a single time point
after their initiation or during their development were described.
By focusing not only on the pathogen, but also the host’s local
immune response, our study allows insights into host–pathogen
interactions at the commencement, progression and regression of
the infection.
Host–pathogen interaction: Identifying the molecular
partners on both sides of chlamydial cell infection
During the biphasic developmental cycle replicating bacte-
ria acquire energy and biosynthetic precursors from the infected
cell. Chlamydiae are capable of modulating cellular functions,
such as apoptotic programs and immune response (see also Sec-
tions “The innate immune response and its interaction with the
adaptive response: Chlamydial infection and the complement sys-
tem” and “The cellular immune response: New insights into MHC
I-mediated presentation of chlamydial antigens”) (reviewed by
Bastidas et al., 2013). Studies on inhibitors of bacterial protein
synthesis suggest that modulation of host cell functions requires
the activity of speciﬁc chlamydial proteins (see also Section “Host
adaptation of C. psittaci: Escape from the avian innate immune
response”).
C. trachomatis dramatically rearranges the architecture of the
eukaryotic host cell including the Golgi apparatus (GA), localiza-
tion and appearance of the microtubule-organizing center (MTOC)
and polarization of migrating cells (Heuer et al., 2009; Heymann
et al., 2013; Johnson et al., 2009; Knowlton et al., 2011). These
 and chemokines, which help to attract other effector cells to the site of infection.
fferentiation of naive T cells to various subtypes of effector CD4+ and CD8+ T cells.
acrophages and helps B-cell production of chlamydia-speciﬁc antibodies, whereas
884 M.R. Knittler et al. / International Journal of Medical Microbiology 304 (2014) 877–893
Fig. 4. Human and zoonotic chlamydial infections result in Golgi fragmentation in human cell lines. (A) HeLa cells were infected with either C. trachomatis L2 or C. psittaci
at  MOI  2. At 26 h p.i., cells were ﬁxed and stained for the Golgi matrix protein, GM130 (in green). Cells were counter-stained using DAPI and analyzed at a Zeiss LSM 780.
Overlay with a phase contrast is shown. Inclusions are indicated using a red line. Scale bar; 10 m.  (B) HeLa cells were infected with C. trachomatis L2 or C. psittaci using
different MOIs. At 26 hpi, cells were ﬁxed and the GA was visualized by GM130 staining. Golgi elements were then quantiﬁed using ImageJ. (C) Intracellular transport and
lipid  supply of chlamydial inclusion. Chlamydia exploits the host’s intracellular trafﬁcking machinery by recruiting the microtubule motor protein dynein to the outer sur-
face  of the vacuole (mediated by IncB), which drives the migration of inclusions toward the minus end of microtubules and the microtubule-organizing center (MTOC), where it
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hanges contribute either directly to bacterial growth or have
mplications on pathogenesis. Currently, it is unknown whether
hese observed changes are speciﬁc for C. trachomatis or if zoonotic
hlamydia strains including C. psittaci can induce similar changes.
e have experimentally addressed this question by comparing
he GA structure in a human cell culture model infected either
ith C. psittaci or C. trachomatis (Fig. 4). Infections resulted in
ragmentation of the GA into smaller Golgi elements, and GM-
30-positive Golgi elements were recruited to C. trachomatis
nclusions. In contrast, C. psittaci-infected cells showed GM-130-
ositive Golgi elements scattered throughout the cytosol with no
bvious recruitment to the inclusions (Fig. 4A). Quantiﬁcation of
he number of Golgi elements demonstrated Golgi fragmentation
s MOI  dependent but more pronounced in the case of C. psittaci
nfections (Fig. 4B). In summary, Golgi fragmentation is a hallmark
f human and zoonotic chlamydial infections at least in a human
ell culture model, but mode of fragmentation and/or trafﬁcking
f fragmented Golgi elements differ between species. These dif-
erences are likely reﬂected in divergence of chlamydial effector
roteins.
All Chlamydiaceae spp. possess genes encoding core components
f a Type III Secretion (TTS) apparatus, a protein transport system
sed by Gram-negative bacteria to translocate proteins into the
ytoplasm of the host cell. Therefore, it is commonly accepted that
hlamydial effector proteins are targeted by the TTS to the inclusion
embrane and that their interaction with host proteins cause the
odulation of host cell functions (Peters et al., 2007). Interactions
f chlamydial effector proteins with host proteins seem to play a
ole at all stages of chlamydial development, i.e. from adhesion and
nternalization of EBs till their exit from the host cell.
An important group of chlamydial effector proteins are the Inc
inclusion) proteins, which share a common secondary structural
eature of a bilobed hydrophobic domain. While this hydropho-
ic domain enables the anchoring of the proteins in the inclusion
embrane, the cytoplasmic tail is responsible for interaction with
ost proteins (Dehoux et al., 2011). By direct interaction with
ost cell proteins, Inc proteins may  affect different cell functions
ncluding signaling and trafﬁcking. One of the ﬁrst discovered
rotein–protein interactions was the association of IncG with
ammalian 14-3-3 protein (Scidmore and Hackstadt, 2001),
hich contributes to circumvention of host cell apoptosis. The Inc
rotein CP0236 impairs IL-17 signaling via interaction with human
ct1 (Wolf et al., 2009). Furthermore, IncD of C. trachomatis was
hown to interact with the lipid transfer protein CERT (Derre et al.,
011), while another Inc protein, CT229, associated with the GTPase
ab4 (Rzomp et al., 2006). Both interactions may  affect trafﬁcking
rocesses of the host cell. Finally, Inc protein CT228 was found to
ecruit elements of the myosin phosphatase pathway to regulate
elease mechanisms (Lutter et al., 2013).
In a recent study, we focused on the IncA and IncB pro-
eins of the zoonotic agent C. psittaci using yeast two-hybrid
creens to search for interacting host proteins that could indicate
unctions of these proteins. In a ﬁrst attempt, the interac-
ion between type III-secreted protein IncA of C. psittaci and
ost protein G3BP1 was identiﬁed. In GST-pull down and co-
mmunoprecipitation experiments both in vitro and in vivo
nteraction between full-length IncA and G3BP1 were shown.
3BP1 harbors a phosphorylation-dependent RNase activity that
peciﬁcally cleaves the 3′-untranslated region of human c-myc
RNA. Using ﬂuorescence microscopy, the localization of G3BP1
ear the inclusion membrane of C. psittaci-infected Hep-2 cells was
esides in a central perinuclear position to establish its intracellular niche near the Golg
lustering around the perinuclear MTOC. During the maturation of inclusions chlamydia
nd  bacterial growth.dical Microbiology 304 (2014) 877–893 885
demonstrated. Notably, infection of Hep-2 cells with C. psittaci and
overexpression of IncA in HEK293 cells led to a decrease in c-Myc
protein concentration. This effect could be ascribed to the inter-
action between IncA and G3BP1 since overexpression of an IncA
mutant construct disabled to interact with G3BP1 failed to reduce
c-Myc concentration. We  hypothesize that lowering the host cell
c-Myc protein concentration may  be part of a strategy employed by
C. psittaci to avoid apoptosis and scale down host cell proliferation
(Borth et al., 2011). Furthermore, it was shown that IncB in early
inclusions of C. psittaci interacts and co-localizes with components
of the dynein complex (data not shown). It is known that within
the ﬁrst few hours of infection, endocytosed C. trachomatis EBs are
transferred to a perinuclear location corresponding to the MTOC
of the host cell using the tubulin–dynein system (Grieshaber et al.,
2003). Like C. trachomatis, C. psittaci also utilizes dynein motor pro-
teins for optimal early development (Escalante-Ochoa et al., 2000).
The interplay of IncB of C. psittaci with dynein components is the
ﬁrst indication of chlamydial proteins being involved in this trans-
port process and possibly affecting the localization and structural
appearance of the MTOC (Heuer et al., 2009) to support bacterial
growth in the infected cell.
Host adaptation of C. psittaci: Escape from the avian innate
immune response
Factors and mechanisms determining host speciﬁcity of Chlamy-
dia spp. are still largely unknown. In a recent study (Braukmann
et al., 2012), C. psittaci and C. abortus were compared for their
invasiveness, virulence, and capability of eliciting an immune
response in a chicken embryo model. This system has been used
for decades, particularly to culture viruses and intracellular bacte-
ria. As it involves inoculation onto the chorioallantoic membrane
(CAM) the model resembles natural infection across epithelial lay-
ers. In fact it represents a valuable tool to investigate the innate
immune response to chlamydial infection and to identify molecu-
lar processes on the pathogen’s side in conjunction with the host’s
response that could explain differences in host adaptation between
chlamydial species.
When compared with C. abortus, which is closely related but
prefers non-avian hosts, C. psittaci displayed a signiﬁcantly better
capability of disseminating in host organs and elicited higher
macrophage numbers and stronger expression of a sub-set of
immune-related proteins. Nevertheless, the immune response
patterns to both pathogens were largely similar, with expression
of the pro-inﬂammatory mediators IL-1, IL-6, IL-8, LITAF, IL-17
and iNOS, as well as IFN-, IL-12, IL-18, and TLR4, being signif-
icantly upregulated in CAM, liver and spleen of C. psittaci- and
C. abortus-infected embryos. However, signiﬁcant differences in
favor of C. psittaci were seen in embryo mortality (Fig. 5) and
mRNA expression rates of chlamydial genes, such as incA, groEL (in
CAM, liver, spleen), cpaf and ftsW (in CAM). It is conceivable that
elevated expression levels of the IncA protein would contribute to
stabilization of the inclusion where the bacteria are residing (see
also Section “Host–pathogen interaction: Identifying the molecular
partners on both sides of chlamydial cell infection”). As expression
of FtsW is used as an indicator of the pathogen’s capability to
replicate in the host, elevated mRNA expression rates of this gene
could explain the better proliferation of C. psittaci throughout
the infection. Furthermore, upregulation of the gene encoding
the chlamydial heat shock protein GroEL (Hsp60) coincided with
the elevated macrophage inﬂux during C. psittaci infection. GroEL
i apparatus. Fusion, maturation and maintenance of chlamydial inclusions require
l effector proteins cause Golgi fragmentation and thereby ensure lipid acquisition
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Fig. 5. Chlamydial infection in chicken embryos. Fertilized chicken eggs were incubated at 37.8 ◦C and a relative humidity of 60%. Inoculation of C. psittaci and C. abortus was
conducted at embryonic developmental day (ED) 10. For infection, the bacterial suspension was  transferred onto the chorioallantoic membrane (CAM (upper left panel)). The
immune response patterns to both pathogens were largely similar, with expression of the pro-inﬂammatory mediators (upper right panel). Signiﬁcant differences in favor
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urves showing the survival of chicken embryos after infection with C. psittaci an
noculated with comparable amounts of chlamydiae (9 × 104–1 × 105 IFU/egg) and 
erves as a chaperone during intracellular development (Zugel
nd Kaufmann, 1999) and seems to be involved in the induction
f immune response during human chlamydial infection, where it
o-localizes with inﬁltrating macrophages (Kol et al., 1999).
Compared to C. abortus, C. psittaci appeared to be more efﬁ-
ient in actively suppressing the host immune response, which
nabled better dissemination in the host. In this context, up-
egulation of cpaf (see also Section “The cellular immune response:
ew insights into MHC  I-mediated presentation of chlamydial
ntigens”) probably enabled the pathogen to inﬂuence the host
eaction in its favor. The results indicate a relevance of incA (see
lso Section “Host-pathogen interaction: Identifying the molec-
lar partners on both sides of chlamydial cell infection”), groEL,
paf and ftsW for the pathogenicity of C. psittaci. The data of
he in vivo study provide a basis for a more detailed insight
nd better understanding of host–pathogen interactions in the
ourse of infection. The fact that C. psittaci coped far better
han C. abortus with the onset of the avian embryo’s innate
mmune response by upregulating selected genes may  be a key
o understanding the mechanisms underlying host adaptation and
tiopathology.t panel), such as incA, groEL, cpaf and ftsW and in embryo mortality. Kaplan–Meier
comparison, C. abortus (Iower panel). On ED 10, embryos (n = 20 per group) were
itality was  determined by daily candling.
The innate immune response and its interaction with the
adaptive response: Chlamydial infection and the
complement system
The complement system consists of approximately 40 serum
factors, mainly zymogens, their cleavage products and receptors. It
is activated by LPS or lectins and other components of bacterial and
viral surfaces. The activated complement system modulates inﬂam-
matory responses and protects against extracellular pathogens.
Complement is often regarded as a key player of innate immu-
nity (which can additionally be activated by immune complexes).
However, there is increasing evidence that it can additionally trig-
ger, enhance and orchestrate adaptive immune responses, at least
in viral infections (reviewed by Klos et al., 2013). A complement
system with homologous factors and identical function was found
not only in mammals, but also in other vertebrate species including
birds (Sharma, 1997).Biologically active cleavage products of the circulating inert
complement factors are locally released upon activation. Some of
them become part of enzyme complexes, which permit successive
steps in the cascade. Others remain soluble, bind to receptors on
M.R. Knittler et al. / International Journal of Medical Microbiology 304 (2014) 877–893 887
Fig. 6. (A) Complement factor C3 provides protection of mice against C. psittaci. C3−/− and the corresponding wild-type (WT) mice were intranasally infected with 104 ifu of
C.  psittaci strain DC15. Survival rates were determined for up to 21 days post-infection. (B) Assumed C3a/C3a-receptor (C3aR)-dependent regulation of the adaptive immune
response against chlamydiae. Chlamydial elementary bodies (green) activate the complement cascade leading to the cleavage of inactive complement factor C3 into active
C3a  and C3b. Bound to its antigen, the C3b derivative C3d stimulates via complement receptor 2 (CR2) B cells and antibody production of plasma cells. The C3aR is expressed
on  mature dendritic cells (DCs) and, most likely, also on various subtypes of activated T cells including CD4+ CD25+ regulatory T cells (Treg cells). For the development of an
effective adaptive protection against the bacteria, the immune-modulator C3a stimulates directly CD4+ (Th1 and Th2) and cytotoxic CD8+ T cells. Alternatively, C3aR-signaling
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hown-regulates Treg cells thereby decreasing their inhibition of CD4+ and CD8+ T ce
he  draining lymph nodes and thus, to an augmented presentation of chlamydial an
he host cell surface and act as extracellular mediators for intra-
ellular signaling events. The three classical and broadly known
ffector functions of the complement cascade, i.e. opsonization via
ntigen-bound C3b, lysis by the membrane attack complex, pro-
nﬂammation via the anaphylatoxins, are located downstream of
omplement factor C3. The anaphylatoxic peptides C3a and C5a,
leavage products of factor C3 and factor C5, respectively, acti-
ate their G-protein coupled receptors. C3a receptor (C3aR) and
5a receptor (C5aR, C5a1 receptor, CD88) are expressed on cells
f myeloic origin including granulocytes, monocytes/macrophages,
Cs, mast cells, and even progenitor cells (see also Sections “Local
mmune response: Development and resolution of pulmonary
esions after C. psittaci infection of calf and mouse” and “The cellular
mmune response: New insights into MHC  I-mediated presentation
f chlamydial antigens”). Moreover, the anaphylatoxin receptors
re also found on several non-myeloic cells and activated T cells.
lbeit C3aR and C5aR are closely related, their functions overlap
nly partially.
EBs of C. trachomatis activate complement in vitro thereby
educing their infectivity in cell culture (Fedorko et al., 1987; Lin
t al., 1992; Megran et al., 1985). Except for this fact, there was only
imited knowledge about the role of complement during infections
ith Chlamydia or other intracellular bacteria at the beginning of
he present research project. In a mouse model of intranasal C.
sittaci lung infection, an early, high and long-lasting activation
f the complement system was found (Bode et al., 2012). Intrigu-
ngly, only after the ﬁrst week of infection complement became
ighly protective with an almost 100-fold increased susceptibilityd DCs. Moreover, C3a/C3aR can activate DCs leading to their improved migration to
s to lymphocytes.
of C3−/− compared to wild type (WT) mice (Fig. 6A). In contrast,
there were only minor differences after C. psittaci infection of com-
plement factor C5-deﬁcient and C5aR−/− in comparison to WT
mice. This indicates that the main protective function of the cas-
cade locates downstream of C3, but upstream of C5. It also points
strongly toward C3a/C3aR as promising candidates of combatants
for an effective defense against this intracellular microorganism.
Indeed, in our most recent study using C3aR−/− mice, the
hypothesis that the C3aR is indispensable for effective protection
and improved survival in C. psittaci lung infection has been con-
ﬁrmed (Dutow et al., 2014). During the ﬁrst week, the course of
disease was almost identical in infected WT  and C3aR−/− mice.
However, from then on, the ability to respond via C3aR to C3a signif-
icantly shortened severe acute pneumonia, led to drastically higher
survival rates, more weight gain and lower clinical score. The bacte-
rial clearance from lung and spleen was impaired in the absence of
C3aR. Inﬂammatory parameters in lung homogenate including sev-
eral cytokines and neutrophil granulocytes (and myeloperoxidase
as granulocyte marker) (see also Section “Local immune response:
Development and resolution of pulmonary lesions after C. psittaci
infection of calf and mouse”) remained elevated in C3aR−/− mice,
as determined 14 days p.i. The most likely explanation for the sus-
tained inﬂammatory response is the ongoing C. psittaci infection
and the higher bacterial burden in the absence of C3aR.Furthermore, the most likely reason for the impaired clearance
of chlamydiae and the high lethality of the C3aR−/− mice during the
second and third weeks p.i. has been addressed The time course
suggested C3a/C3aR-dependent effects on the adaptive immune
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esponse. Indeed, the size of the lung-draining lymph nodes of
3aR−/− mice increased less during chlamydial infection until day
, i.e. the last time point before C3−/− and C3aR−/− animals can
o longer control chlamydial infection and start to die. Intrigu-
ngly, cellular and adaptive immune responses were impaired in the
bsence of C3aR. The numbers of CD4+ T cells and of re-stimulated
hlamydia-speciﬁc IFN-+ CD4+ and CD8+ cells in lung-draining
ymph nodes were smaller; and there was no signiﬁcant increase in
 cells during infection. Following the same line, C3aR−/− mice were
argely incapable of chlamydia-speciﬁc IgM or IgG production. To
ddress causality and mechanism of C3aR-dependent protection
n regard to the diminished antibody response, a serum trans-
er experiment was performed. Transfer of hyperimmune serum
efore infection could partially reverse the lethal outcome in
3aR−/− mice, indicating that antibody responses participate in
rotection against C. psittaci re-infection. This is in agreement with
arlier reports, which indicated antibody-mediated protection in
. trachomatis and C. muridarum reinfections, suggesting a general
unction of antibodies in protection against secondary chlamydial
nfections (Morrison and Morrison, 2005; Su et al., 1997).
In contrast, transfer of C. psittaci-speciﬁc IgG to C3aR−/− mice on
ay 7, i.e. during ongoing acute infection, had only a very limited
ffect on disease progression and did not reduce lethality at all.
his indicates that, in addition to the humoral response, other C3a-
ependent functions must be critical for recovery and the much
etter survival rate of WT  mice in our model of primary infec-
ion. CD4+ and CD8+ T cells each are sufﬁcient for effective defense
gainst C. pneumoniae, with IFN- as key player (Rothfuchs et al.,
004), suggesting a similar role of these T cell subsets in the defense
gainst C. psittaci (see also Section “The cellular immune response:
ew insights into MHC  I-mediated presentation of chlamydial
ntigens”). Thus, impaired C. psittaci-speciﬁc CD4+ and cytotoxic
D8+ T cell responses in infected C3aR−/− mice are presently the
ost likely causal link and explanation for the C3a-dependent pro-
ection in primary infection. Regulatory T cells, which suppress
unctions of both T cells and DCs and which can be downregulated
y C3a (and C5a), might also participate in the immune dysfunction
bserved in the absence of C3aR in our model (for an illustration of
he assumed C3aR-dependent regulation of the adaptive immune
esponse against C. psittaci and protection, see Fig. 6B).
The studies described in this section showed that complement,
nd C3a and its receptor in particular, are critical for defense
gainst C. psittaci in murine lung infection. However, it appears that
he classical effector functions of the complement system are not
mportant in this defense. Intriguingly, it seems as though C3a acts
ess as a weak pro-inﬂammatory mediator, but more as a powerful
odulator of the adaptive cellular and humoral reactions against
. psittaci.  Enhancement of speciﬁc B and T cell responses upon
nfection with an intracellular bacterium were identiﬁed as hitherto
nknown features of complement and C3aR. These new functions
ight be of general immunological importance beyond chlamydial
nfections.
he cellular immune response: New insights into MHC
-mediated presentation of chlamydial antigens
It has been speculated that CD8+T cells primed during chlamy-
ia infection may  lyse infected cells and deprive the pathogen
f its intracellular niche (Balsara and Starnbach, 2007). If lysis
f infected cells occurs early enough in the chlamydial develop-
ental cycle, when the majority of organisms are non-infectious
Bs, this mechanism could dramatically slow down the spread
f infection within the host. In addition to this protective role
f CD8+ T cells during infection, there is evidence for the impor-
ance of IFN- release from activated CD8+ T cells in controllingdical Microbiology 304 (2014) 877–893
chlamydia infection (Starnbach et al., 1994). The initiation of
the adaptive immune response (see also Section “Local immune
response: Development and resolution of pulmonary lesions after
C. psittaci infection of calf and mouse”) requires MHC-mediated
antigen presentation (Raghavan et al., 2008). In particular, DCs
(see also Sections “Local immune response: Development and res-
olution of pulmonary lesions after C. psittaci infection of calf and
mouse” and “The innate immune response and its interaction with
the adaptive response: Chlamydial infection and the complement
system”) are equipped with a specialized machinery that promotes
effective display of MHC/peptide complexes, rendering them the
most potent stimulators of T lymphocytes (Thacker and Janssen,
2012). DCs perform a kind of sentinel function due to their ability
to process internalized antigens before migration to secondary lym-
phoid organs, where they stimulate different sets of T cells (Thacker
and Janssen, 2012). In the classical MHC  I-pathway of antigen pre-
sentation, cytosolic antigens are degraded into peptide fragments
by the proteasome and transported from the cytosol into the ER
lumen by peptide transporter TAP (Raghavan et al., 2008). Peptides
are then loaded on newly synthesized MHC  I, and these complexes
are released from the ER and transported to the cell surface via
the Golgi (Peaper and Cresswell, 2008). DCs, however, have devel-
oped the ability to efﬁciently present peptides derived from endo-
as well as exogenous antigens on MHC  I via a process called cross-
presentation (Neefjes and Sadaka, 2012). DCs are among the ﬁrst
professional antigen presenting cells (APCs) that are encountered
by chlamydiae during infection (Gervassi et al., 2004) (see also
Section “Local immune response: Development and resolution of
pulmonary lesions after C. psittaci infection of calf and mouse”). It
is thought that T cells primed by infected DCs play an important
role in the effective immune response against chlamydia infec-
tion (Ojcius et al., 1998). The strategies used by the mammalian
adaptive immune system (e.g. human and murine) are also mir-
rored in other jawed vertebrates, such as birds, so that, generally
speaking, the avian innate and adaptive immune systems strongly
resemble those of mammals (Foster and Berndt, 2013; Rolstad and
Fossum, 1990; Sharma, 1997). Notably, pathogen-speciﬁc T and
B cell responses combating chlamydial (Vanrompay et al., 1999)
or other bacterial infections (Carvajal et al., 2008) and provid-
ing protection were also observed in birds. Moreover, since the
avian immune system is also comprised of B, T, and NK cells, DCs,
macrophages, as well as cyto/chemokines, it seems straightforward
to speculate that mammals and birds use comparable immune
mechanisms to elicit anti-chlamydial immunity.
In recent studies, a mouse model (see also Sections “Local
immune response: Development and resolution of pulmonary
lesions after C. psittaci infection of calf and mouse” and “The innate
immune response and its interaction with the adaptive response:
Chlamydial infection and the complement system”) was used to
analyze cellular and molecular requirements of MHC  I-cross pre-
sentation of C. psittaci-infected myeloid (m)DCs (Fiegl et al., 2013).
These DCs display morphological as well as functional maturation,
which depend mainly on TLR2 signaling and are characterized by
formation of dendritic veils, decreased phagocytic activity, ele-
vated expression of distinct activation/maturation markers, as well
as secretion of mDC-speciﬁc chemo/cytokines that are associated
with optimal antigen presentation to T cells and the clearance of
infection (Fiegl et al., 2013). Most interestingly, infected DCs permit
only a restricted developmental cycle of chlamydiae. Thus, multiple
small inclusions containing predominantly RBs, also at late stages
of cell infection, are a typical feature (Fiegl et al., 2013). A controlled
survival of chlamydiae in infected DCs might be critical to ensure a
broad antigen reservoir allowing sustained and efﬁcient chlamydial
antigen presentation. The restricted growth of chlamydiae in DCs
is induced by TNF- that interferes with the developmental cycle.
The limited growth of C. psittaci in infected DCs is accompanied by
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Fig. 7. Amphisomal cross-presentation of chlamydial antigens. Chlamydial inclusions formed in infected DCs are characterized by structural disintegration. Cytosolic released
bacteria are engulfed by autophagosomes, which are able to fuse with endosomal compartments. Chlamydial antigens are preprocessed in these amphisomes and are then
transferred across endo-vacuolar membranes for ﬁnal processing by the proteasome. Antigenic peptides are reimported by TAP into amphisomal compartments and bound
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cn  MHC  I derived from endosomal recycling of surface molecules. MHC I successfu
hich they recycle back to the “loading compartment”. Depicted immunoﬂuoresc
efense  machinery including small HSPs, GBP1 as well as autophagy markers and t
etention of the chlamydial protease CPAF (see also Section “Host
daptation of C. psittaci:  Escape from the avian innate immune
esponse”) within bacterial compartments, structural disintegra-
ion of inclusions and autophagosomal degradation of released free
ytosolic chlamydiae (Fiegl et al., 2013). CPAF had been postulated
o be the main virulence factor of chlamydiae (Shaw et al., 2002).
t was proposed that the bacterial protease degraded various host
actors relevant for chlamydial intracellular survival and that the
ytosolic presence of CPAF played an essential role in maintainingded with chlamydial antigens is presented on the cell surface to CD8+ T cells from
images show colocalization of chlamydia with different effectors of the host cell
sence of MHC I in cathepsin D-positive compartments.
the structural integrity of bacterial inclusions (Jorgensen et al.,
2011). However, the ﬁndings of a recent study by Chen et al.
(2012) have raised signiﬁcant doubt that the identiﬁed host factors
represent real substrates for CPAF in infected host cells. These new
data exact a re-interpretation of the role of this bacterial enzyme
during infection and fresh investigations on any CPAF functions.
By analyzing the stress response of Chlamydia-infected DCs, we
observed an infection-dependent up-regulation of cytoprotective
small HSPs (heat-shock proteins), which are known to interact
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ith the cellular cytoskeleton. This process is accompanied by
 pronounced co-localization between the HSPs and chlamyd-
al structures. Further experiments showed that knockdown of
mall HSPs in infected cells resulted in an increase in the bac-
erial load of infected cells with intact parasitophorous vacuoles
ncapsulated by actin ring structures. We  suggest that the observed
ffects of infection-induced HSPs are likely due to direct interven-
ions on chlamydial cytoskeleton subversion and in turn structural
isintegration of chlamydial compartments. Moreover, our stud-
es revealed up-regulation of the host defense factor GBP1 in
hlamydia-infected DCs, which targets cytosolic released chlamy-
iae to autophagosomes to confer cell-autonomous protection
nd defense against the pathogen (Fiegl et al., 2013). Autophagy
s a fundamental cellular mechanism essentially involved in the
egradation of intracellular structures (Huang and Brumell, 2009)
nd has a protective function against cell-invading microbes. Our
esults suggest that chlamydiae from disintegrated inclusions
re efﬁciently guided to autophagosomal compartments termed
mphisomes, which are in close proximity to the collapsed chla-
ydial structures (Fiegl et al., 2013).
It was also found that chlamydiae do apparently not inter-
ere with the ability of DCs to present MHC  I-bound antigens
Fiegl et al., 2013). Thus, C. psittaci-infected mature DCs showed
ncreased expression, surface recycling and presentation of MHC
 (Fiegl et al., 2013). The induction of MHC  I depends on the
resence of TNF- (Fiegl et al., 2013), which is released by
hlamydia-infected DCs in response to TLR2 signaling (Prebeck
t al., 2001). Chlamydia-infected DCs are also characterized by
ncreased presence of MHC  I and TAP in endosomal compartments
ontaining cathepsin D and S (Fiegl et al., 2013). Both hydro-
ases are known to function as important downstream proteases
n autolysosomal/amphisomal degradation (Boland et al., 2008;
an et al., 2012). Inhibition of the two cathepsins in infected DCs
as a dramatic inﬂuence on the MHC  I-mediated stimulation of
hlamydia-speciﬁc CD8+ T cells suggesting important functions for
he MHC  I-processing of chlamydial antigens (Fiegl et al., 2013).
athepsin-generated precursor peptides are thought to require fur-
her downstream trimming for MHC  I loading (Fonteneau et al.,
003). In accordance with this idea, we found that the proteasome
nhibition affects functional MHC  I-presentation to chlamydia-
peciﬁc CD8+ T cells, indicating a signiﬁcant contribution of the
roteasome in the generation of chlamydial antigens. It appears
hat chlamydial antigens are ﬁrst processed in amphisomal com-
artments, where cathepsins cleave bacterial proteins into large
eptides. After cytosolic re-translocation, predigested peptides
re further degraded by the proteasome and are then handled
y TAP, which is also critically required for functional process-
ng of chlamydial antigens. On the basis of the work described
n this section, we propose a new cross-presentation model in
hich autophagy constitutes an important pathway promoting
roteasome/TAP-dependent MHC  I processing of chlamydial anti-
ens (Fig. 7).
Clearance of chlamydiae depends on the ability of CD8+ T cells
o recognize epithelial cells, in which the bacteria predominantly
eplicate (Balsara and Starnbach, 2007) (see also Sections 3 and 4).
ur recent studies demonstrate that chlamydia-infected epithelial
ells retain their full ability to perform MHC  I-mediated antigen
resentation in the presence and absence of IFN- (Kägebein et al.,
014). One could imagine that, in chlamydia-infected epithelial
ells, IFN- from activated T cells creates a situation reﬂecting the
bove-described scenario for infected DCs. Indeed, our own  studies
nd those of other groups showed that, in infected epithelial cells,
FN- restricts chlamydial growth (Kägebein et al., 2014; Morrison,
003) affects cytoplasmic CPAF translocation (Heuer et al., 2003),
nd induces autophagic degradation of chlamydiae (Al-Zeer et al.,
009).dical Microbiology 304 (2014) 877–893
Our recent ﬁndings on MHC  I antigen presentation in chlamydia-
infected DCs, epithelial cells and ﬁbroblasts provide important
novel insights for the development of such future strategies
designed to support and maintain T cell-mediated immune
responses against chlamydial infections.
Conclusions and outlook
Morbidity and mortality resulting from chlamydial diseases are
of major global signiﬁcance. The zoonotic potential of C. psittaci
is an important and ongoing challenge for research and practice
in human and veterinary medicine. The German national net-
work on “Zoonotic chlamydiae – Models for chronic and persistent
infections in man  and animals” addressed distinct interconnected
questions relating to chlamydial genomics and pathology, as well as
host–pathogen interaction and anti-bacterial immunity. The indi-
vidual studies of this coordinated research effort revealed
- the plasticity zone of the C. psittaci genome harboring key
genomic correlates to species-speciﬁc adaptation to environmen-
tal niches, tissue tropism, virulence and pathogenicity,
- a broadened understanding of the complexity between patho-
logical changes, pathophysiological interactions and the clinical
outcome of an acute C. psittaci infection in the mammalian lung
including the resulting systemic consequences,
- new insights into the early events of anti-chlamydial immune
response and tissue regeneration in different hosts,
- signiﬁcant differences and similarities between molecular fac-
tors and mechanisms of individual chlamydial pathogens, which
might help to develop future strategies for disease control,
- the experimental basis to unravel the mechanisms underlying
immune escape and host adaptation in the course of C. psittaci
infection,
- a previously unknown important protective function of the com-
plement system, particularly of C3a/C3aR, in C. psittaci infection
of the lung,
-  new insights into the role of C3a/C3aR on the development of
an effective adaptive immune response against these (and most
likely also other) intracellular bacteria, and
- new intracellular pathways of cell-intrinsic immunity and MHC
I-mediated antigen presentation.
Although efﬁcacious antimicrobial therapies exist, vaccination
is still considered to be the best approach to reduce the prevalence
of chlamydial infections. However, currently, there are no vaccines
available against chlamydial infection despite the many efforts that
have been made throughout the years. Our ﬁndings will not only
help to develop innovative intervention and vaccination strategies
against chlamydial infections, but also provide comparative data for
other infectious agents. Clearly, further intensive research on chla-
mydial infections is required, especially with regard to treatment of
persistent varieties, host adaptation, co-infection with other intra-
cellular pathogens and bacterial mechanisms of immune evasion.
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